Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zevra Therapeutics Inc.

    NASDAQ: ZVRA · Real-Time Price · USD
    8.81
    -0.31 (-3.45%)
    At close: Jun 17, 2025, 3:59 PM
    8.79
    -0.28%
    After-hours: Jun 17, 2025, 04:41 PM EDT

    Zevra Therapeutics Statistics

    Share Statistics

    Zevra Therapeutics has 54.68M shares outstanding. The number of shares has increased by 29.3% in one year.

    Shares Outstanding

    n/a
    		 54.68M

    Shares Change (YoY)

    n/a
    		 29.3%

    Shares Change (QoQ)

    n/a
    		 1.39%

    Owned by Institutions (%)

    n/a
    		 70.96%

    Shares Floating

    n/a
    		 54.08M

    Failed to Deliver (FTD) Shares

    n/a
    		 17,983

    FTD / Avg. Volume

    n/a
    		 3.25%

    Short Selling Information

    The latest short interest is 5.67M, so 10.37% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.67M

    Short % of Shares Out

    n/a
    		 10.37%

    Short % of Float

    n/a
    		 10.43%

    Short Ratio (days to cover)

    n/a
    		 9.66

    Valuation Ratios

    The PE ratio is -3.66 and the forward PE ratio is 13.6. Zevra Therapeutics's PEG ratio is -0.05.

    PE Ratio

    n/a
    		 -3.66

    Forward PE

    n/a
    		 13.6

    PS Ratio

    n/a
    		 16.34

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 9.72

    P/FCF Ratio

    n/a
    		 -5.54

    PEG Ratio

    n/a
    		 -0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Zevra Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.53, with a Debt / Equity ratio of 1.52.

    Current Ratio

    n/a
    		 2.53

    Quick Ratio

    n/a
    		 2.47

    Debt / Equity

    n/a
    		 1.52

    Debt / EBITDA

    n/a
    		 -0.79

    Debt / FCF

    n/a
    		 -0.87

    Interest Coverage

    n/a
    		 -11.84

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $400,203.39

    Profits Per Employee

    n/a
    		 $-1,788,322.03

    Employee Count

    n/a
    		 59

    Asset Turnover

    n/a
    		 0.13

    Inventory Turnover

    n/a
    		 3.76

    Taxes

    Income Tax

    n/a
    		 15.37M

    Effective Tax Rate

    n/a
    		 -17.05%

    Stock Price Statistics

    The stock price has increased by 97.98% in the last 52 weeks. The beta is 1.99, so Zevra Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.99

    52-Week Price Change

    n/a
    		 97.98%

    50-Day Moving Average

    n/a
    		 8.02

    200-Day Moving Average

    n/a
    		 8.09

    Relative Strength Index (RSI)

    n/a
    		 52.74

    Average Volume (20 Days)

    n/a
    		 553,482

    Income Statement

    In the last 12 months, Zevra Therapeutics had revenue of 23.61M and earned -105.51M in profits. Earnings per share was -2.28.

    Revenue

    n/a
    		 23.61M

    Gross Profit

    n/a
    		 16.2M

    Operating Income

    n/a
    		 -87M

    Net Income

    n/a
    		 -105.51M

    EBITDA

    n/a
    		 -76.4M

    EBIT

    n/a
    		 -82.79M

    Earnings Per Share (EPS)

    n/a
    		 -2.28
    Full Income Statement

    Balance Sheet

    The company has 33.78M in cash and 60.3M in debt, giving a net cash position of -26.51M.

    Cash & Cash Equivalents

    n/a
    		 33.78M

    Total Debt

    n/a
    		 60.3M

    Net Cash

    n/a
    		 -26.51M

    Retained Earnings

    n/a
    		 -505.29M

    Total Assets

    n/a
    		 172.71M

    Working Capital

    n/a
    		 54.6M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -69.67M and capital expenditures 0, giving a free cash flow of -69.67M.

    Operating Cash Flow

    n/a
    		 -69.67M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -69.67M

    FCF Per Share

    n/a
    		 -1.51
    Full Cash Flow Statement

    Margins

    Gross margin is 68.59%, with operating and profit margins of -368.47% and -446.85%.

    Gross Margin

    n/a
    		 68.59%

    Operating Margin

    n/a
    		 -368.47%

    Pretax Margin

    n/a
    		 -381.76%

    Profit Margin

    n/a
    		 -446.85%

    EBITDA Margin

    n/a
    		 -323.56%

    EBIT Margin

    n/a
    		 -368.47%

    FCF Margin

    n/a
    		 -295.04%

    Dividends & Yields

    ZVRA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ZVRA is $21.5, which is 144% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $21.5

    Price Target Difference

    n/a
    		 144%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 28, 2020. It was a backward split with a ratio of 1:16.

    Last Split Date

    n/a
    		 Dec 28, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:16

    Scores

    Altman Z-Score

    n/a
    		 -2.74

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist